The UK NSC recommendation on Hepatitis B screening in pregnancy

Recommendation Systematic population screening programme recommended
Last review completed July 2006
Next review due in n/a

Evidence to support continuation or cessation of existing screening programmes should be reviewed regularly. The process for this is currently being revised, which is why this topic does not currently have a review date. The new process will be published in due course. Each programme has an active portfolio of research, evidence and audit to support continual improvement. Find out more about hepatitis B screening as part of the infectious diseases in pregnancy screening programme in England.


Find general information about population health screening.

More about Hepatitis B

Hepatitis B and C are serious viral diseases which affect the liver and are blood borne. Both viruses may cause acute illness. However, in the majority of children these viruses become chronic with liver damage only becoming apparent in adulthood. The common way of spreading or acquiring the infection are babies born to hepatitis B or C positive mothers, sharing of toothbrushes or razors amongst family members, or intravenous drug abuse. 

Mothers can pass on their infection to their baby. An infected baby may develop liver problems later in life. This can be prevented by immunisation of the newborn baby. 

» Read more about Hepatitis B on NHS Choices


British Society for Immunology
Royal College of Obstetricians and Gynaecologists

The stakeholder groups will be involved when the recommendation is next reviewed. If you think your organisation should be added, please contact us. More information for stakeholders can be found in appendix C of the UK NSC evidence review process.

More options

Go to top